about
The heat shock protein 90 inhibitor BIIB021 suppresses the growth of T and natural killer cell lymphomas.Induction of Epstein-Barr Virus Oncoprotein LMP1 by Transcription Factors AP-2 and Early B Cell FactorTofacitinib induces G1 cell-cycle arrest and inhibits tumor growth in Epstein-Barr virus-associated T and natural killer cell lymphoma cellsThe Epstein-Barr virus BRRF2 gene product is involved in viral progeny production.Epstein-Barr Virus BKRF4 Gene Product Is Required for Efficient Progeny Production.The Epstein-Barr Virus BRRF1 Gene Is Dispensable for Viral Replication in HEK293 cells and Transformation.The C-Terminus of Epstein-Barr Virus BRRF2 Is Required for its Proper Localization and Efficient Virus Production.A Herpesvirus Specific Motif of Epstein-Barr Virus DNA Polymerase Is Required for the Efficient Lytic Genome Synthesis.The Epstein-Barr Virus BDLF4 Gene Is Required for Efficient Expression of Viral Late Lytic Genes.Roles of Epstein-Barr virus BGLF3.5 gene and two upstream open reading frames in lytic viral replication in HEK293 cells.Characterization of a Suppressive Cis-acting Element in the Epstein-Barr Virus LMP1 Promoter.Antitumor effects of duvelisib on Epstein-Barr virus-associated lymphoma cells.Initial Characterization of the Epstein⁻Barr Virus BSRF1 Gene ProductDefective Epstein-Barr virus in chronic active infection and haematological malignancyPublisher Correction: Defective Epstein-Barr virus in chronic active infection and haematological malignancyAntitumor activity of cyclin-dependent kinase inhibitor alsterpaullone in Epstein-Barr virus-associated lymphoproliferative disordersThe BOLF1 gene is necessary for effective Epstein-Barr viral infectivityEpstein-Barr Virus BBRF2 Is Required for Maximum InfectivityOncolytic activity of HF10 in head and neck squamous cell carcinomas
P50
Q35336213-868D28BF-E720-46D0-AD66-15044B0814FAQ36736410-94E4958C-7B9F-43F3-9D47-F031BB6D10B4Q38741546-306F83E0-2C5F-49D4-9E37-7D06AD2722B8Q38865835-DEC449B0-5AD3-4D75-94FF-6935E0901BB3Q40042387-7079B44F-7660-485F-A16B-70A9F197FD0EQ40114050-22AB8EE7-CD31-42BD-B190-12CF0E103D25Q40333251-5959FA91-1067-4FE1-9D57-A5AF47E9162BQ40784228-AD2E4EE8-4E5B-432D-9B3F-3BDEAD85FCEFQ41094782-E7DE6604-E084-4220-82B7-091C54F7BC93Q41238337-ED30C2BE-0E0C-4A45-8AC3-F2A4E7612272Q45323690-81907A3A-B895-48A4-B9D8-D1437271384EQ52664561-E4CBC920-2CCD-4C3D-9A3A-D6266BDF3554Q64068330-7335E82E-2663-4236-81F4-1EFCA6066D9BQ91142437-0F7D6956-F94C-43A8-9F0E-1A403B936455Q91297763-BAD15CBD-CE7D-4246-AD83-5E0E6C5E0828Q91339392-63D1D0F3-4850-44FF-872E-62D8C8DF078DQ92270405-D14AE199-E740-4AD8-9563-2A1B39BFDE0AQ92328499-36486D64-A0C1-4A85-9D19-FE2FF685A446Q93064425-54F924E6-C7A5-49C6-A38F-4E31C83A11B3
P50
description
investigador
@es
researcher
@en
wetenschapper
@nl
name
Takahiro Watanabe
@en
Takahiro Watanabe
@nl
type
label
Takahiro Watanabe
@en
Takahiro Watanabe
@nl
prefLabel
Takahiro Watanabe
@en
Takahiro Watanabe
@nl
P31
P496
0000-0002-7249-8106